The Latest in Rheumatology

Internal Medicine News

Tofacitinib postmarketing trial data shed light on JAK inhibitor risks

November 16, 2021

Internal Medicine News

Allopurinol proves noninferior to febuxostat for gout relief

November 12, 2021

Rheumatology

Internal Medicine News

mRNA COVID vaccine response found mostly robust in RA, SLE patients

November 11, 2021

Internal Medicine News

When a JAK inhibitor fails for a patient with RA, what’s next?

November 10, 2021

Rheumatology

Internal Medicine News

Statins’ effects on CVD outweigh risk for diabetes in RA

November 9, 2021

Internal Medicine News

Genotype, need for transfusion predict death in VEXAS syndrome

November 9, 2021

Internal Medicine News

Lupus patients in remission see more flares with HCQ reduction, discontinuation

November 9, 2021

Rheumatology

Internal Medicine News

Rituximab improves systemic sclerosis skin, lung symptoms

November 8, 2021

Internal Medicine News

Psoriatic arthritis and axial spondyloarthritis patients succeed with reduced TNF inhibitor dosing

November 8, 2021

Rheumatology

Internal Medicine News

Risankizumab outperforms placebo at 6 months for psoriatic arthritis

November 8, 2021

Rheumatology

Internal Medicine News

Abatacept shows signal to delay onset of rheumatoid arthritis

November 8, 2021

Rheumatology

Internal Medicine News

Vitamin D and omega-3 supplements reduce autoimmune disease risk

November 7, 2021

Internal Medicine News

Risk for VTE in RA may be higher with MTX vs. hydroxychloroquine

November 2, 2021

Rheumatology

Internal Medicine News

PT may lower risk of long-term opioid use after knee replacement

November 1, 2021

Internal Medicine News

Higher odds for preterm, C-section births seen in women with PsA

October 28, 2021